LIXTE Biotechnology Holdings, Inc. Announces 1-For-10 Reverse Stock Split Of Its Common Stock Effective On Pre-Market Opening On June 5, 2023
Portfolio Pulse from Happy Mohamed
LIXTE Biotechnology Holdings, Inc. (NASDAQ:LIXT) announced a 1-for-10 reverse stock split of its common stock, effective on June 5, 2023. The move aims to increase the per share trading price and bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing.

June 02, 2023 | 4:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
LIXTE Biotechnology's 1-for-10 reverse stock split aims to increase the per share trading price and comply with Nasdaq's minimum bid price requirement.
The reverse stock split is intended to increase LIXTE's per share trading price, which may help the company maintain its listing on the Nasdaq Capital Market. However, there is no guarantee that the company will remain in compliance with the minimum bid price requirement or other Nasdaq listing requirements. The short-term impact on the stock price is neutral, as the reverse stock split is a technical adjustment and does not change the company's fundamentals.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100